UNSPSC 51161517: Zileuton

This classification denotes a lipooxygenase inhibitor with the molecular formula C11H12N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V1L22WVE2S, chemically known as urea, n-(1-benzo(b)thien-2-ylethyl)-n-hydroxy- but generally known as zileuton, which bears US NIH Compound Identifier 60490. European Medicines Agency schedules Zileuton in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00157MIG.

UNSPSC 51161517 Zileuton (Commodity) describes pharmaceutical products, but the recent state and local solicitation activity under this code reflects procurement of emergency response pharmaceuticals and drug deactivation systems rather than the specific asthma medication the code nominally names. Seminole County, Florida is actively seeking naloxone and safe drug deactivation systems through competitive bidding, signaling that state and local health agencies are using this code space to source rapid-response medications and harm-reduction equipment. The scope includes annual procurement volumes (1,900 units of naloxone and 800 deactivation systems in the Seminole County case), with quarterly delivery cadences to designated health facilities. Issuing bodies soliciting under this code appear to include county health departments and municipal community health agencies focused on public health emergency response and substance-use support initiatives.

Seminole County's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2026, represents the most recent documented opportunity. The procurement specifies electronic bid submission through the county's e-Procurement Portal, inclusion of all shipping and delivery costs in proposals, and a two-year initial term with one-year renewal option. Vendors must meet standard compliance requirements including drug-free workplace certification, E-Verify verification, and specified insurance coverage. The solicitation notes potential FEMA funding with associated federal regulatory compliance obligations. Florida shows recent activity under this code; the geographic spread and issuing-body concentration cannot be fully characterized from a single recent opportunity.